Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1755-1776
Author(s):
A. Yermakova and M. K. O'Banion
Positron Emission Tomography in Drug Development and Drug Evaluation
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1583-1591
Author(s):
A. M. J. Paans and W. Vaalburg
PET Studies of Brain Monoamine Transporters
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1611-1623
Author(s):
Aki Laakso and Jarmo Hietala
Interferon gama induced Tryptophan Degradation Neuropsychiatric and Immunological Consequences
Journal:
Current Drug Metabolism
Volume:
1
Page:
193-204
Author(s):
B. Widner, M. Ledochowski and D. Fuchs
Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer
Journal:
Current Drug Targets
Volume:
1
Page:
163-183
Author(s):
Charleata A. Carter
Modulation of the Ceramide Level, A Novel Therapeutic Concept
Journal:
Current Drug Targets
Volume:
1
Page:
185-205
Author(s):
R. Claus, S. Russwurm, M. Meisner, R. Kinscherf and H. P. Deigner
Dopamine Agonists in the Treatment of Parkinsons Disease-Past, Present and Future
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1211-1248
Author(s):
S. Y. Sit
Ginkgo Biloba Extract (EGb 761) and CNS Functions Basic Studies and Clinical Applications
Journal:
Current Drug Targets
Volume:
1
Page:
25-58
Author(s):
F. V. DeFeudis and K. Drieu
P-glycoprotein as a Drug Target in the Treatment of Multidrug Resistant Cancer
Journal:
Current Drug Targets
Volume:
1
Page:
85-99
Author(s):
Gustav Lehne
Current Gene Therapy Strategies for Colorectal Cancer
Journal:
Current Genomics
Volume:
1
Page:
103-115
Author(s):
Rachel Hargest